VOLITIONRX

VNRX AMEX
3.580
+0.030
+0.85%
Opening 11:32 07/23 EDT
Open
3.620
Prev Close
3.550
High
3.650
Low
3.560
Volume
26.92K
Avg Vol (3M)
62.11K
52 Week High
3.650
52 Week Low
1.440
% Turnover
0.07%
Market Cap
141.34M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers VOLITIONRX VNRX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
MORE >

Recently

Name
Price
%Change